GC Therapeutics claims it can create off-the-shelf therapies from induced pluripotent stem cells faster and simpler than current methods.

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

Of course, GC Therapeutics could also mean gene and cell therapeutics ... diseases to broaden access to cell therapies.

gene editing, cell engineering and machine learning to overcome the development and scaling complexities associated with cell therapy and improve patient access across a broad range of disease areas.

Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million people worldwide. The ...

What is precision therapy ... gene in lung cancer can be treated using targeted drugs like EGFR tyrosine kinase inhibitors or ALK inhibitors. How can it help prescribe targeted therapies? Genomics ...

FRIDAY, Sept. 6, 2024 (HealthDay News) -- Gene therapy may restore vision to children and adults robbed of their sight by a rare inherited condition called Leber congenital amaurosis, researchers ...

I am writing this story on behalf of Gene Pachio, a 64-year-old veteran from Grass Valley, CA. We are writing you with the hope that this will shed light on some serious issues with Veterans Affairs, ...

approved the first cellular therapy for aggressive forms of melanoma. The treatment, called Amtagvi, is "designed to fight off advanced forms of melanoma by extracting and replicating T cells ...

Study reveals how aging accelerates molecular changes in the brain, offering new hope for tackling cognitive decline and mental illness. Resource: Single-nucleus transcriptomic profiling of human ...

But while largely ignored by busy individuals and most insurance plans, biopharma R&D—specifically cell and gene therapy—is paying attention. Let’s start with hearing. The human ear is made up of ...

Cambridge, MA, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Cambridge, MA, August 29, 2024 – As gene and cell therapy and gene editing technologies continue to revolutionize the treatment of genetic ...